Skip to main content
PREDILIFE logo

PREDILIFE — Investor Relations & Filings

Ticker · ALPRE ISIN · FR0010169920 LEI · 9695006IK5NBKHQU9116 PA Human health and social work activities
Open in API
Filings indexed 150 across all filing types
Latest filing 2021-05-20 Regulatory Filings
Country FR France
Listing PA ALPRE

About PREDILIFE

https://www.predilife.com/en/

PREDILIFE specializes in predictive medicine, developing solutions to assess an individual's risk of developing major diseases. The company's approach integrates medical data, such as genetic testing and imaging, with artificial intelligence and mathematical models to create personalized risk profiles. Its primary offerings are predictive health check-ups, including a specialized test for assessing the 5-year risk of breast cancer (MammoRisk®) and a multi-condition check-up that evaluates the risk for several common cancers (lung, prostate, colorectal, melanoma) and cardiovascular disease. Based on these risk profiles, PREDILIFE provides personalized follow-up and preventive recommendations. The company offers its end-to-end solution, which includes remote consultations, to businesses, insurers, and healthcare professionals to facilitate wider access to preventive care.

Recent filings

Filing Released Lang Actions
SIGNATURE D'UN CONTRAT AVEC L'UNIVERSITE DE GENEVE POUR LA REALISATION DES ANALYSES GENETIQUES MULTIPATHOLOGIES
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) dated May 20, 2021, announcing the signing of a contract with the University of Geneva for genetic analysis. It details a business development (partnership/contract signing) and includes contact information for Investor Relations and Press. This type of announcement, focusing on a specific business event or contract, is typically classified as a general regulatory announcement or news release that doesn't fit the specific financial report categories (like 10-K, ER, IR). Given the options, it is best categorized as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the contract implied significant financial impact, but since it's a standard business development press release, RNS is the most appropriate fallback for non-standard announcements.
2021-05-20 French
PREDILIFE : RÉSULTATS ANNUELS 2020
Earnings Release Classification · 1% confidence The document is titled "PREDILIFE : RÉSULTATS ANNUELS 2020" and is dated April 30, 2021. It presents selected financial information for the year ended December 31, 2020, including revenue, operating result, and net result, comparing them to 2019. It also discusses capital increases and post-closing events. Crucially, the final section states: "Le rapport financier annuel au 31 décembre 2020, intégrant le rapport de gestion, les comptes annuels et consolidés 2020 ainsi que les rapports des commissaires aux comptes sur lesdits comptes, est mis à disposition du public ce jour." This structure—a press release summarizing annual results and announcing the availability of the full annual financial report—is characteristic of an Earnings Release (ER). While it contains annual results, it is presented as a summary announcement rather than the comprehensive 10-K filing itself. Given the content focuses on the announcement of the annual results, ER is the most appropriate classification over 10-K (which is the formal SEC filing) or AR (which is usually a standalone audit report). FY 2020
2021-04-30 French
SUCCES DE L'OFFRE AU PUBLIC D'OBLIGATIONS CONVERTIBLES
Capital/Financing Update Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) dated April 27, 2021, and its primary subject is announcing the success and results of a public offering of convertible bonds (OCEANE). It details the amount raised (€2.5 million), the intended use of funds (accelerating B2C offering and commercial deployment), and the resulting dilution calculations for shareholders. This content directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report publication (RPA), as it contains substantive financial and structural details about the completed financing event.
2021-04-27 French
PREDILIFE PROLONGE LA PERIODE DE SOUSCRIPTION DE SON OFFRE AU PUBLIC D'OBLIGATIONS CONVERTIBLES A UN TAUX DE 7% PAR AN
Capital/Financing Update Classification · 1% confidence The document is a 'COMMUNIQUE DE PRESSE' (Press Release) dated April 14, 2021. The core subject is the extension of the subscription period for a public offering of convertible bonds ('obligations convertibles'). This announcement details changes to the financing timeline, increases the maximum offering amount, and provides theoretical dilution impacts on equity per share and shareholder stakes. This content directly relates to fundraising, financing activities, and capital structure changes. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report publication (RPA), as it contains substantive details about the financing terms and schedule.
2021-04-14 French
PREDILIFE ETEND SON RESEAU DE DISTRIBUTION AU MOYEN ORIENT
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) dated March 30, 2021. It announces a specific business event: PREDILIFE signing a distribution agreement with Mena Medical Development for its Mammorisk® product in the Middle East. This type of announcement, detailing a strategic partnership or business development, is typically classified as a general regulatory announcement or press release that doesn't fit the highly specific financial report categories (like 10-K, ER, IR). Since it is a formal announcement of a business event, and not a detailed financial report, dividend notice, or management change, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous official announcements.
2021-03-30 French
PREDILIFE ELARGIT SON OFFRE DE PREDICTION A LA CARDIOLOGIE
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) dated March 23, 2021. It announces a business development: PREDILIFE is expanding its risk prediction offering to include cardiology, specifically mentioning the CE marking of a medical device for heart attack risk prediction. This is a general announcement about a product/business update, not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed investor presentation (IP). Since it is a press release announcing a significant business event (product expansion/regulatory milestone), it fits best under the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS), or potentially a general announcement if RNS is reserved strictly for stock exchange filings. Given the context of a press release announcing a business development, RNS is the most appropriate general category for non-standard announcements.
2021-03-23 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.